FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
Author: admintech | Filed under: World
This entry was posted
on Tuesday, December 22nd, 2020 at 7:13 am and is filed under World.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.